Viewing Study NCT04380103


Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2025-12-29 @ 5:57 AM
Study NCT ID: NCT04380103
Status: UNKNOWN
Last Update Posted: 2020-05-08
First Post: 2020-05-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer
Sponsor: Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module